PER 0.00% 10.0¢ percheron therapeutics limited

News: ANP Antisense Therapeutics says ATL1102 for MS Phase IIb IND submitted to FDA for review, page-40

  1. 4,103 Posts.
    lightbulb Created with Sketch. 1866
    Logzy you miss understand me I meant ethical will not get their hands on mine as shortfall
    Obvious they want to get all they can
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.